Related Experiment Video
Updated: Oct 8, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in
1Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-744, Korea.
Abstract:
Although TGF-beta1, a growth inhibitor, is known to also induce apoptosis, the molecular mechanism of this apoptosis is largely undefined. Here, we identify the mechanism of TGF-beta1-induced apoptosis in SNU-16 human gastric cancer cells. Cell cycle and TUNEL analysis showed that, upon TGF-beta1 treatment, cells were initially arrested at the G1 phase and then driven into apoptosis. Of note, caspase-3 was activated in accordance with TGF-beta1-induced G1 arrest. Activated caspase-3 is targeted to cleave p21(cip1), p27(kip1), and Rb, which play important roles in TGF-beta-induced G1 arrest, into inactive fragments. Subsequently, Cdk2 was aberrantly activated due to the cleavage of p21 and p27. We found that the inhibition of Cdk2 activity efficiently blocks TGF-beta1-induced apoptosis, whereas it did not prevent caspase-3 activation or the subsequent cleavage of target proteins. In contrast, the suppression of caspase-3 activity inhibited the cleavage of target proteins, the activation of Cdk2, and the induction of apoptosis. Taken together, our results suggest that activation of caspase-3 by TGF-beta1 may initiate the conversion from G1 cell cycle arrest to apoptosis via the cleavage of p21, p27 and Rb, which in turn causes Cdk2 activation and, most significantly, Cdk2 activation as a downstream effector of caspase is a critical step for the execution of TGF-beta1-induced apoptosis.
Insights
Transforming growth factor-beta1 (TGF-β1) induces apoptosis in gastric cancer cells by activating caspase-3. This caspase cleaves cell cycle proteins, leading to aberrant Cdk2 activation and cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta1 (TGF-β1) is a known growth inhibitor that can also induce apoptosis.
- The precise molecular mechanisms underlying TGF-β1-induced apoptosis remain largely undefined.
Purpose of the Study:
- To elucidate the mechanism of TGF-β1-induced apoptosis in SNU-16 human gastric cancer cells.
- To identify the key molecular players and pathways involved in this process.
Main Methods:
- Cell cycle analysis and TUNEL assay to assess cell cycle progression and apoptosis.
- Western blotting and caspase activity assays to evaluate protein cleavage and enzyme activation.
- Inhibition of Cdk2 and caspase-3 activities to determine their roles in apoptosis.
Main Results:
- TGF-β1 treatment induced G1 cell cycle arrest followed by apoptosis.
- Caspase-3 activation occurred concurrently with G1 arrest and was responsible for cleaving p21(cip1), p27(kip1), and Rb.
- Cleavage of p21 and p27 led to aberrant Cdk2 activation, which was essential for TGF-β1-induced apoptosis.
- Inhibition of Cdk2 blocked apoptosis but not caspase-3 activation, while caspase-3 inhibition prevented Cdk2 activation and apoptosis.
Conclusions:
- TGF-β1-induced apoptosis involves caspase-3 activation, which initiates the transition from G1 arrest to apoptosis.
- Cleavage of cell cycle regulators (p21, p27, Rb) by caspase-3 leads to Cdk2 activation.
- Cdk2 activation downstream of caspase-3 is a critical execution step for TGF-β1-induced apoptosis in gastric cancer cells.
Related Concept Videos
Caspases
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
